Martha Hernández, a scientist at CloudLIMS, breaks down the regulatory changes that US hemp testing labs need to be prepared for.
The study also showed that adolescents’ risk for cannabis use differed based on the type of mental health problems they experienced.
Ahead of Oregon's psilocybin legalization initiative, researchers at Oregon Health & Science University reviewed the evidence base for the therapeutic use of the drug.
The study tracked the symptoms of 186 cannabis card holders who suffered from either insomnia, anxiety, depression, or pain. Only the insomnia patients reported significant improvements in their symptoms.
Learn about the emergence of psychedelic drugs, their importance & how a Laboratory Information Management System (LIMS) can assure their quality testing.
Regular cannabis consumers tend to have a lower resting heart rate than those who don’t use the drug, according to a new study.
Despite this retraction the original study’s main conclusion, that cannabis legalization doesn’t seem to encourage adolescent use of the drug, remains intact.
To learn more about the event and what attendees can expect, Analytical Cannabis caught up with one its speakers, Dr Callie Seaman, an honorary researcher at Sheffield Hallam University and executive director and scientific lead at Medcan Support.